Scarica l'app Stockscreener
55.36
6.50%
3.38
Eton Pharmaceuticals Inc Borsa (ETON) Ultime notizie
Eton Pharmaceuticals Inc (ETON) Shares Fall 13.0% -- What GF Sco - GuruFocus
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Down 7.4%Here's Why - MarketBeat
Bank of America Corp DE Acquires New Shares in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
How IMPAVIDO Rights Deal At Eton Pharmaceuticals (ETON) Has Changed Its Investment Story - Simply Wall Street
Form 8K Eton Pharmaceuticals Inc For: 28 September By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals launches IMPAVIDO for leishmaniasis By Investing.com - Investing.com Australia
Eton Pharmaceuticals launches IMPAVIDO for leishmaniasis - Investing.com
Eton Pharmaceuticals Launches IMPAVIDO in the U.S. with Expanded Patient Support and Specialty Pharmacy Access - Quiver Quantitative
Eligible commercially insured patients have a $0 copay option for IMPAVIDO. Eton has launched it in the U.S. - Stock Titan
Understanding Momentum Shifts in (ETON) - Stock Traders Daily
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Eton Pharmaceuticals stock gains 6.98 percent after Q2 results - AD HOC NEWS
ETON Stock Price, Quote & Chart - ChartMill
Is Eton Pharmaceuticals Inc (ETON) Overvalued After 7.0% Rally? - GuruFocus
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9%Should You Buy? - MarketBeat
Eton Pharmaceuticals stock reports 99 percent Q2 revenue growth - AD HOC NEWS
Eton Pharmaceutcials (ETON) Stock Price, News & Analysis - Stock Titan
Eton Pharmaceuticals stock edges higher after strong 2025 growth figures - AD HOC NEWS
Eton Pharmaceuticals stock holds steady as insider sales and recent results shape the picture - AD HOC NEWS
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 24.41% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Eton Pharmaceuticals stock holds steady as investors eye latest results - AD HOC NEWS
Liquidity Mapping Around (ETON) Price Events - Stock Traders Daily
Squarepoint Ops LLC Invests $2.16 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
HighTower Advisors LLC Acquires 34,484 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Hsbc Holdings PLC Makes New $1.53 Million Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Heads To Wells Fargo Conference As Fair Value Debate Stays Open - simplywall.st
Eton Pharmaceuticals Inc (NASDAQ: ETON) Share Price, ETON Stock News, ETON Share Price & Updates - Kalkine
118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS
Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga
Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Q2 2026 Earnings: EPS Soars Past Estimates on Strong Operational ExecutionOperating Income Trends - careplusvn.com
Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media
Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan
34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Slips 1.74% as Shares Pull Back Toward Key SupportPCR Mean Reversion - dars.gov.et
Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE - MarketBeat
1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC - MarketBeat
Cannell Capital LLC Acquires New Stake in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Director Sells $2,953,500.00 in Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ: ETON) insider sells 50K shares - Stock Titan
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETON - marketbeat.com
Eton Pharmaceuticals Insider Sold Shares Worth $2,953,572, According to a Recent SEC Filing - Yahoo Finance
Eton leaders will hold one-on-one meetings at Wells Fargo’s Boston event - stocktitan.net
Pillsbury Lake Capital LLC Invests $14.02 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference - Yahoo Finance
Eton's Galzin TM And False Ad Suit Survives Dismissal Bid - Law360
Eton Pharmaceuticals Can Proceed With ‘Gluzin’ Supplement Suit - Bloomberg Law News
Insider Unloading: David Krempa Sells Options, Realizes $1.43MEton Pharmaceuticals (NASDAQ:ETON) - Benzinga
Eton Pharmaceuticals stock hits all-time high at 64.29 USD By Investing.com - Investing.com India
Eton (ETON) Financial Results: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Post-Report: Shares Move 5.94% UpDividend Cut Risk - vinanet.vn
Eton Pharmaceuticals Insider Sold Shares Worth $1,626,750, According to a Recent SEC Filing - Yahoo Finance
Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore - Sahm
Eton Pharmaceuticals Inc (ETON) Stock Up 5.9% but GF Value Says Overvalued -- GF Score: 58/100 - GuruFocus
SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock - Benzinga
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock By Investing.com - Investing.com India
Eton Pharmaceuticals CEO Sean Brynjelsen Executes Four Stock Sales Over Two Days - Kalkine Media
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock - Investing.com
1.15%
5.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):